AstraZeneca PLC said Tuesday it paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.
AstraZeneca, which licensed the vaccine from developers at the University of Oxford, said the pause will allow an independent committee to review safety data.
The pause affects a study…